Zimmer Biomet Earns 510(k) for G7 TM Acetabular System .
The article reports that Zimmer Biomet has received U.S. Food & Drug Administration (FDA) 510(k) clearance to market its G7 TM Acetabular System, a next-generation hip replacement implant designed for challenging primary and revision total hip arthroplasty cases. The system builds on the established G7 platform by combining Trabecular Metal® porous technology with a strategically placed anatomic screw-hole pattern and Rim Fix™ screws to support stable fixation in compromised bone and promote biological integration. It is compatible with multiple G7 liners, including dual mobility and constrained options, and is expected to begin U.S. commercialization with full launch anticipated by the end of the first quarter of 2026.
Read the full News article from BoneZone
Read Article
DESCARGO DE RESPONSABILIDAD
El contenido de esta página tiene únicamente fines informativos y no pretende sustituir el consejo, diagnóstico o tratamiento médico profesional. Si necesita tratamiento médico, busque siempre el consejo de su médico o acuda al servicio de urgencias más cercano. Las opiniones, creencias y puntos de vista expresados por las personas sobre el contenido que se encuentra en esta página no reflejan las opiniones, creencias y puntos de vista de OrthoEvidence.
